Pingyu Liu

Dr. Pingyu Liu


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2022 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
XHXue Hao
Xue Hao
YSYusuke Shiromoto
Yusuke Shiromoto
MSMasayuki Sakurai
Masayuki Sakurai
MTMartina Towers
Martina Towers
QZQiang Zhang
Qiang Zhang
RZRugang Zhang
Rugang Zhang

1 June 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
TFTakeshi Fukumoto
Takeshi Fukumoto
JLJianhuang Lin
Jianhuang Lin
NFNail Fatkhutdinov
Nail Fatkhutdinov
PLPingyu Liu
Pingyu Liu
RSRajasekharan Somasundaram
Rajasekharan Somasundaram
CNChikako Nishigori
Chikako Nishigori

28 February 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
LYLi Yang
Li Yang
JYJianwei You
Jianwei You
XYXincheng Yang
Xincheng Yang
RJRuishu Jiao
Ruishu Jiao
JXJie Xu
Jie Xu
PLPingyu Liu
Pingyu Liu
Senescence-associated secretory phenotype (SASP) mediates the biological effects of senescent cells on the tissue microenvironment and contributes to ageing-associated disease progression. ACSS2 produces acetyl-CoA from acetate and epigenetically controls gene expression through histone acetylation under various circumstances. However, whether and how ACSS2 regulates cellular senescence remains unclear. Here, we show that pharmacological inhibition and deletion of Acss2 in mice blunts SASP and abrogates the pro-tumorigenic and immune surveillance functions of senescent cells. Mechanistically, ACSS2 directly interacts with and promotes the acetylation of PAICS, a key enzyme for purine biosynthesis. The acetylation of PAICS promotes autophagy-mediated degradation of PAICS to limit purine metabolism and reduces dNTP pools for DNA repair, exacerbating cytoplasmic chromatin fragment accumulation and SASP. Altogether, our work links ACSS2-mediated local acetyl-CoA generation to purine metabolism through PAICS acetylation that dictates the functionality of SASP, and identifies ACSS2 as a potential senomorphic target to prevent senescence-associated diseases.